Boxpot of tNAA/tCr in patients with secondary progressive Multiple Sclerosis (SPMS) in normal appearing white matter (NAWM) at baseline (0 months) and end of study (24 months).

Abstract

<p>Boxpot of tNAA/tCr in patients with secondary progressive Multiple Sclerosis (SPMS) in normal appearing white matter (NAWM) at baseline (0 months) and end of study (24 months).</p

    Similar works

    Full text

    thumbnail-image

    Available Versions